Clare Atzema Archives - Emergency Medicine Cases

Episode 41: Hypertensive Emergencies

In this episode on Hypertensive Emergencies, Dr. Joel Yaphe, EM residency program director at the University of Toronto & Dr. Clare Atzema, one of Canada's leading cardiovascular EM researchers will discuss the controversies of how to manage patients who present to the ED with high blood pressure and evidence of end organ damage related to the high blood pressure. Hypertensive emergencies are a grab bag of diagnoses that all need to be treated differently. Hypertensive Encephalopathy, Aortic Dissection, Acute Pulmonary Edema, Pre-eclampsia & Eclampsia, Acute Renal Failure, Subarachnoid Hemorrhage and Intracranial Hemorrhage all need individualized blood pressure management.

By Anton Helman|2021-03-30T17:11:48-04:00March 24th, 2014|Categories: Cardiology, EM Cases, Emergency Medicine, Episodes, Resuscitation|Tags: acute renal failure, aortic dissection, Clare Atzema, congestive heart failure, eclampsia, hypertensive encephalopathy, intractranial hemorrhage, Joel Yaphe, labetolol, nicardipine, nitroprusside, subarachnoid hemorrhage|14 Comments

Episode 40: Asymptomatic Hypertension

University of Toronto EM Residency program director, Joel Yaphe and cardiovascular EM researcher, Clare Atzema discuss the guidelines, controversies, pearls & pitfalls of Asymptomatic Hypertension in the ED. The literature is thin in this area, and there are many controversies: Does an elevated BP measured in the ED represent true essential hypertension? Do these patients need to be worked up? Are they at risk of serious morbidity and mortality? Should we treat these patients in the ED with antihypertensives? Should we send them home on antihypertensives? and many more......

By Anton Helman|2021-06-21T17:11:53-04:00February 20th, 2014|Categories: Cardiology, EM Cases, Emergency Medicine, Episodes|Tags: ACE Inhibitor, acep guidelines, antihypertensive, b-blocker, calcium channel blocker, Clare Atzema, feature, hydralazine, hydrocholorthiazide, hypertensive emergency, Joel Yaphe|2 Comments

Episode 20: Atrial Fibrillation

In this episode Dr. Clare Atzema, Dr. Nazanin Meshkat and Dr. Bryan Au discuss the presentation, etiology, precipitants, management and disposition of Atrial Fibrillation in the Emergency Department. The pros and cons of rate and rhythm control are debated, what you need to know about rate and rhythm control medications reviewed, and the strength of the Ottawa Aggressive Protocol discussed. The importance of appropriate anticoagulation is detailed, with a review of the CHADS-VASc score and whether to use Warfarin, Dabigatran or ASA for stroke prevention for patient with Atrial Fibrillation. We end off with a discussion on how to recognize and treat Wolff-Parkinson-White syndrome in the setting of Atrial Fibrillation.

By Anton Helman|2021-09-23T18:05:58-04:00February 9th, 2012|Categories: Cardiology, EM Cases, Emergency Medicine, Episodes, Resuscitation|Tags: anticoagulants, anticoagulation, CHADS Score, Clare Atzema, clinical decision rule, dabigitran, Warfarin|1 Comment

Best Case Ever 7: Atrial Fibrillation

As a bonus to Episode 20 on Atrial Fibrillation, we present here, Dr. Clare Atzema, a leading EM researcher in Atrial Fibrillation, telling her Best Case Ever related to Afib. What would you do if you needed to cardiovert a patient who was too obese to fit on an ED stretcher? Dr. Atzema, along with Dr. Nazanin Meshkat and Dr. Bryan Au, discuss the presentation, etiology, precipitants, management and disposition of Atrial Fibrillation in the Emergency Department. The pros and cons of rate vs rhythm control are debated, what you need to know about Afib medications, and the value of the Ottawa Aggressive Protocol discussed. The importance of appropriate anticoagulation is detailed, with a review of the CHADS-VASc score and whether to use anticogulants or ASA for stroke prevention for patients with Afib. We end off with a discussion on how to recognize and treat Wolff-Parkinson-White syndrome in the setting of Atrial Fibrillation. [wpfilebase tag=file id=382 tpl=emc-play /] [wpfilebase tag=file id=383 tpl=emc-mp3 /]

By Anton Helman|2016-10-20T13:24:00-04:00February 2nd, 2012|Categories: Best Case Ever, Cardiology, EM Cases, Emergency Medicine, Resuscitation|Tags: anticoagulation, cardioversion, Clare Atzema, clinical decision rules, dabigitran, ottawa aggressive protocol, Warfarin, wolff-parkinson-white|1 Comment